BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 28, 2010
View Archived Issues
Exelixis claims novel mTOR and PI3K-alpha inhibitors
Read More
German scientists identify new cysteine protease inhibitors
Read More
Lilly identifies novel selective estrogen receptor modulators
Read More
Merck & Co. claims novel mGlu2 receptor agonists
Read More
Final data disclosed from PROTECT trial of PEG-IFN-alfa2b/ribavirin
Read More
HCV NS5B polymerase inhibitor ABT-072 shows promising safety and pharmacokinetics
Read More
Serum markers may identify children who will develop active multiple sclerosis
Read More
Greater HbA1c reductions with LY-2189265 in Hispanic patients with type 2 diabetes
Read More
Cancer cell stemness inhibitor BBI-608 safe and active in ongoing phase I trial
Read More
No endocrine safety concerns noted in phase II trials of ulipristal acetate for uterine fibroids
Read More
Amgen provides product and pipeline update for first quarter of 2010
Read More
ALN-RSV01 may benefit lung transplant patients with RSV infection
Read More
Santaris advances SPC-5001 into development to lower cholesterol
Read More
PAION and FDA agree on design phase IIb trial of CNS-7056
Read More
Biotie reports encouraging topline phase I data on ELB-353
Read More
Living Cell Technologies receives grant from JDRF for phase II DiabeCell trial
Read More
ViroPharma begins phase II trial of subcutaneous Cinryze in HAE
Read More
Cleveland BioLabs opens U.S. office of Incuron to develop anticancer curaxins
Read More
CHMP adopts positive opinion for variation to terms of Reyataz marketing authorization
Read More
Rosuvastatin gains new indication to prevent major cardiovascular events
Read More
Dynavax reports preclinical data on universal flu vaccine candidate
Read More
Logical Therapeutics begins phase IIb safety trial of naproxen etemesil
Read More
FDA clears NexMed's phase II PrevOnco trial in advanced unresectable hepatocellular cancer
Read More
Ophthotech enrolls first patient in phase II E-10030 trial in macular degeneration
Read More
Sirion Therapeutics launches Zirgan in U.S. for ocular herpes
Read More
TRACON starts phase I/II TRC-105 trial in prostate cancer
Read More